These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 15558238

  • 1. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures.
    Oleksik AM, Ewing S, Shen W, van Schoor NM, Lips P.
    Osteoporos Int; 2005 Aug; 16(8):861-70. PubMed ID: 15558238
    [Abstract] [Full Text] [Related]

  • 2. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study.
    Silverman SL, Minshall ME, Shen W, Harper KD, Xie S, Health-Related Quality of Life Subgroup of the Multiple Outcomes of Raloxifene Evaluation Study.
    Arthritis Rheum; 2001 Nov; 44(11):2611-9. PubMed ID: 11710717
    [Abstract] [Full Text] [Related]

  • 3. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures.
    Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, Kanis J.
    J Bone Miner Res; 2000 Jul; 15(7):1384-92. PubMed ID: 10893688
    [Abstract] [Full Text] [Related]

  • 4. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, Grassi W, Italian Multicentre Osteoporotic Fracture Study Group.
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [Abstract] [Full Text] [Related]

  • 5. The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.
    Oglesby AK, Minshall ME, Shen W, Xie S, Silverman SL.
    J Rheumatol; 2003 Jul; 30(7):1579-83. PubMed ID: 12858462
    [Abstract] [Full Text] [Related]

  • 6. Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial.
    Silverman S, Viswanathan HN, Yang YC, Wang A, Boonen S, Ragi-Eis S, Fardellone P, Gilchrist N, Lips P, Nevitt M, Palacios Gil-Antuñano S, Pavelka K, Revicki D, Simon J, Macarios D, Siris ES.
    Osteoporos Int; 2012 Apr; 23(4):1361-9. PubMed ID: 21769664
    [Abstract] [Full Text] [Related]

  • 7. [The impact of subclinical vertebral fractures on health-related quality of life in women with osteoporosis].
    Alekna V, Tamulaitiene M, Būtenaite V.
    Medicina (Kaunas); 2006 Apr; 42(9):744-50. PubMed ID: 17028473
    [Abstract] [Full Text] [Related]

  • 8. Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis.
    Maricic M, Adachi JD, Sarkar S, Wu W, Wong M, Harper KD.
    Arch Intern Med; 2002 May 27; 162(10):1140-3. PubMed ID: 12020184
    [Abstract] [Full Text] [Related]

  • 9. Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures.
    Romagnoli E, Carnevale V, Nofroni I, D'Erasmo E, Paglia F, De Geronimo S, Pepe J, Raejntroph N, Maranghi M, Minisola S.
    Osteoporos Int; 2004 Dec 27; 15(12):975-80. PubMed ID: 15118812
    [Abstract] [Full Text] [Related]

  • 10. [The impact of vertebral fractures on quality of life in postmenopausal women with osteoporosis. Validity of the Italian version of mini-Osteoporosis Quality of Life Questionnaire.].
    Salaffi F, Stancati A, Carotti M, Lorenzetti R, Grassi W.
    Reumatismo; 2005 Dec 27; 57(2):83-96. PubMed ID: 15983631
    [Abstract] [Full Text] [Related]

  • 11. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation.
    Siris E, Adachi JD, Lu Y, Fuerst T, Crans GG, Wong M, Harper KD, Genant HK.
    Osteoporos Int; 2002 Nov 27; 13(11):907-13. PubMed ID: 12415439
    [Abstract] [Full Text] [Related]

  • 12. Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.
    Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis JA, Kellingray S, Leplege A, Liberman UA, McCloskey E, Minne H, Reeve J, Reginster JY, Scholz M, Todd C, de Vernejoul MC, Wiklund I.
    Osteoporos Int; 1999 Nov 27; 10(2):150-60. PubMed ID: 10501796
    [Abstract] [Full Text] [Related]

  • 13. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
    Bouxsein ML, Chen P, Glass EV, Kallmes DF, Delmas PD, Mitlak BH.
    J Bone Joint Surg Am; 2009 Jun 27; 91(6):1329-38. PubMed ID: 19487509
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL, Shen W, Minshall ME, Xie S, Moses KH.
    J Rheumatol; 2007 Jan 27; 34(1):140-4. PubMed ID: 17216681
    [Abstract] [Full Text] [Related]

  • 15. Health-related quality of life and radiographic vertebral fracture.
    Cockerill W, Lunt M, Silman AJ, Cooper C, Lips P, Bhalla AK, Cannata JB, Eastell R, Felsenberg D, Gennari C, Johnell O, Kanis JA, Kiss C, Masaryk P, Naves M, Poor G, Raspe H, Reid DM, Reeve J, Stepan J, Todd C, Woolf AD, O'Neill TW.
    Osteoporos Int; 2004 Feb 27; 15(2):113-9. PubMed ID: 14618303
    [Abstract] [Full Text] [Related]

  • 16. Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatide.
    Crans GG, Silverman SL, Genant HK, Glass EV, Krege JH.
    Arthritis Rheum; 2004 Dec 27; 50(12):4028-34. PubMed ID: 15593198
    [Abstract] [Full Text] [Related]

  • 17. Back pain-related disability and quality of life in patients affected by vertebral fractures: data from baseline characteristics of population enrolled in Denosumab In Real Practice (DIRP).
    Moretti A, Gimigliano F, Di Pietro G, Gimigliano R, Iolascon G.
    Aging Clin Exp Res; 2015 Oct 27; 27 Suppl 1():S3-9. PubMed ID: 26210371
    [Abstract] [Full Text] [Related]

  • 18. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.
    Delmas PD, Genant HK, Crans GG, Stock JL, Wong M, Siris E, Adachi JD.
    Bone; 2003 Oct 27; 33(4):522-32. PubMed ID: 14555255
    [Abstract] [Full Text] [Related]

  • 19. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E, Selby P, Davies M, Robinson J, Francis RM, Adams J, Kayan K, Beneton M, Jalava T, Pylkkänen L, Kenraali J, Aropuu S, Kanis JA.
    J Bone Miner Res; 2004 May 27; 19(5):728-36. PubMed ID: 15068495
    [Abstract] [Full Text] [Related]

  • 20. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA, Johansson H, Oden A, McCloskey EV.
    Bone; 2009 Jun 27; 44(6):1049-54. PubMed ID: 19254788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.